GlycoEra’s Series B Cash Will Fund Efforts To Take On FcRn Inhibitor Class

venture capital funding. green papaka, text on page wooden background.
GlycoEra raises a $130 series B round • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Therapy Areas